Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Paclitaxel
  • Taxoids

abstract

  • This first randomized trial in this setting demonstrates that D75 every 3 weeks can offer clinically meaningful benefit to patients with advanced NSCLC whose disease has relapsed or progressed after platinum-based chemotherapy.

publication date

  • June 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10856094

Additional Document Info

start page

  • 2354

end page

  • 62

volume

  • 18

number

  • 12